Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long non‐coding RNA FEZF1‐AS1 promotes breast cancer stemness and tumorigenesis via targeting miR‐30a/Nanog axis
Zhi Zhang, Liwei Sun, Yixuan Zhang, et al.
Journal of Cellular Physiology (2018) Vol. 233, Iss. 11, pp. 8630-8638
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis
Guan-Ming Lu, Yueyong Li, Yanfei Ma, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 244
Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway
Ang Zheng, Xinyue Song, Lin Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 122
Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis
Amelia Acha‐Sagredo, Bubaraye Uko, Paschalia Pantazi, et al.
British Journal of Cancer (2020) Vol. 122, Iss. 7, pp. 1050-1058
Open Access | Times Cited: 98
Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
Xiaoying Li, Yang Li, Xinmiao Yu, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 87
Nanog, as a key cancer stem cell marker in tumor progression
Parisa Vasefifar, Rouhollah Motafakkerazad, Leili Aghebati‐Maleki, et al.
Gene (2022) Vol. 827, pp. 146448-146448
Closed Access | Times Cited: 69
Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity
Rui Zhang, Juchuanli Tu, Suling Liu
Seminars in Cancer Biology (2021) Vol. 82, pp. 11-25
Open Access | Times Cited: 62
Crosstalk between long noncoding RNA and microRNA in Cancer
Rahul Bhattacharjee, Neeraj Prabhakar, Lamha Kumar, et al.
Cellular Oncology (2023) Vol. 46, Iss. 4, pp. 885-908
Open Access | Times Cited: 38
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 24
Research progress on the interactions between long non‑coding RNAs and microRNAs in human cancer (Review)
Sun Binyu, Chunxia Liu, H Li, et al.
Oncology Letters (2019)
Open Access | Times Cited: 65
Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications
Q. Huang, Guofeng Liu, Xianling Qian, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1802-1802
Open Access | Times Cited: 59
Noncoding RNAs: the shot callers in tumor immune escape
Lei Liu, Qin Wang, Zhilin Qiu, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 57
New insights into the interaction between m6A modification and lncRNA in cancer drug resistance
Yizhou Jin, Zhipeng Fan
Cell Proliferation (2023) Vol. 57, Iss. 4
Open Access | Times Cited: 18
The oncogenic potential of NANOG: An important cancer induction mediator
Basira Najafzadeh, Zahra Asadzadeh, rohollah motafakker azad, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 4, pp. 2443-2458
Closed Access | Times Cited: 50
Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
Sangita Sridharan, Cory M. Howard, Augustus M. C. Tilley, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 47
LncRNA SPRY4‐IT1 regulates breast cancer cell stemness through competitively binding miR‐6882‐3p with TCF7L2
Xinyue Song, Xiaoxue Zhang, Xinnan Wang, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 1, pp. 772-784
Open Access | Times Cited: 47
Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis
Heng Song, Hui Li, Xiaosong Ding, et al.
International Journal of Oncology (2020) Vol. 57, Iss. 6, pp. 1333-1347
Open Access | Times Cited: 41
circRNA hsa_circ_0018414 inhibits the progression of LUAD by sponging miR-6807-3p and upregulating DKK1
Yuanshan Yao, Yinjie Zhou, Qingwang Hua
Molecular Therapy — Nucleic Acids (2021) Vol. 23, pp. 783-796
Open Access | Times Cited: 40
The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications
Sha Qin, Yitao Mao, Haofan Wang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 11, pp. 2718-2736
Open Access | Times Cited: 36
Metformin and long non-coding RNAs in breast cancer
Morteza Gholami, Zeynab Nickhah Klashami, Pirooz Ebrahimi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316
Feng Wang, Yanwen Zu, Weiping Huang, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 504, Iss. 1, pp. 171-176
Closed Access | Times Cited: 33
The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs
Justin M. Brown, Marie‐Claire D. Wasson, Paola Marcato
Cells (2020) Vol. 9, Iss. 3, pp. 763-763
Open Access | Times Cited: 32
FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies
Changlong Shi, Li Sun, Yongsheng Song
Bioscience Reports (2019) Vol. 39, Iss. 6
Open Access | Times Cited: 30
LINC02381 aggravates breast cancer through the miR‐1271‐5p/FN1 axis to activate PI3K/AKT pathway
Shoucheng Huang, Ping Huang, Huazhang Wu, et al.
Molecular Carcinogenesis (2021) Vol. 61, Iss. 3, pp. 346-358
Closed Access | Times Cited: 27
Functional interplay between long non-coding RNAs and Breast CSCs
Bashdar Mahmud Hussen, Ramiar Kamal Kheder, Sara Tharwat Abdullah, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 17
LINC01857 as an oncogene regulates CREB1 activation by interacting with CREBBP in breast cancer
Youyi Xiong, Yuanting Gu, Fang Wang, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 8, pp. 14031-14039
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top